Examkin

Question

Difficulty: HardInterpreting Imaging Results

A 63-year-old man with a 45-pack-year smoking history is evaluated in the pulmonary clinic. A routine preoperative chest radiograph reveals an incidental 14-mm noncalcified nodule in the peripheral right upper lobe. He has no hemoptysis, weight loss, or prior history of malignancy. To appropriately guide management, assume that the results of each subsequent diagnostic test continue to raise the suspicion for a primary lung malignancy without confirming a definitive diagnosis. Arrange the following radiological evaluations and image-guided procedures in the most appropriate chronological sequence for the diagnostic workup of this patient's solitary pulmonary nodule.

  1. 1Retrieval and comparison of prior thoracic imaging studies
  2. 2Thin-section computed tomography (CT) of the chest without intravenous contrast
  3. 3Fluorodeoxyglucose positron emission tomography (FDG-PET) scan
  4. 4Computed tomography (CT)-guided percutaneous core needle biopsy

Answer

The correct sequence is: 1) Retrieval of prior thoracic imaging studies, 2) CT of the chest without intravenous contrast, 3) FDG-PET scan, and 4) CT-guided percutaneous core needle biopsy.
The evaluation of a solitary pulmonary nodule requires a rigid, stepwise approach to minimize unnecessary invasive procedures. The sequence begins with the least invasive and most definitive historical test: comparing old radiographs to assess for 2-year stability. If the nodule is new or old films are unavailable, a non-contrast thin-section CT is performed to delineate anatomical features and determine the exact size. For solid nodules >8 mm with suspicious features, an FDG-PET scan is indicated to assess metabolic activity and stage the mediastinum and distant sites. Finally, if the PET scan reveals avidity indicative of malignancy, an image-guided biopsy (such as CT-guided for a peripheral lesion) is performed to secure a definitive tissue diagnosis.

Step-by-Step Solution

1
Determine if the nodule is new or chronologically stable.
Retrieval and comparison of prior thoracic imaging studies.
If the nodule has been stable for more than 2 years, it is considered benign and no further workup is needed. This is the safest, most cost-effective, and most essential initial step.
2
Characterize the anatomical features of the nodule.
Thin-section computed tomography (CT) of the chest without intravenous contrast.
Once the nodule is determined to be new, growing, or if prior films are unavailable, a non-contrast CT characterizes the size, borders (e.g., spiculation), and internal density better than plain radiography, guiding the subsequent risk stratification.
3
Assess the metabolic activity and stage the patient.
Fluorodeoxyglucose positron emission tomography (FDG-PET) scan.
For solid nodules >8 mm lacking definitively benign characteristics on CT, a PET scan helps differentiate benign from malignant lesions based on glucose uptake and screens for regional lymph node involvement or distant metastases.
4
Obtain definitive tissue diagnosis.
Computed tomography (CT)-guided percutaneous core needle biopsy.
With a PET-avid peripheral nodule, a CT-guided percutaneous biopsy provides the necessary tissue to confirm the histopathology and molecular profile before planning definitive surgical or oncologic therapy.

Key Concept

The diagnostic algorithm for an indeterminate solitary pulmonary nodule >8 mm prioritizes non-invasive historical comparison, followed by high-resolution anatomical characterization (CT), metabolic assessment and staging (PET), and finally invasive tissue sampling (biopsy).
Rate this question

Topics

Interpreting Imaging Results

More questions from this topic